Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Metabolic–Redox Circuits for Cancer Therapy
Kui Wang, Jingwen Jiang, Yunlong Lei, et al.
Trends in Biochemical Sciences (2019) Vol. 44, Iss. 5, pp. 401-414
Closed Access | Times Cited: 142

Showing 1-25 of 142 citing articles:

mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
Karen Griselda de la Cruz-López, Mariel Esperanza Toledo Guzmán, Elizabeth Sánchez, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 178
Catalytically Active CoFe2O4 Nanoflowers for Augmented Sonodynamic and Chemodynamic Combination Therapy with Elicitation of Robust Immune Response
Shiyan Fu, Ruihao Yang, Junjie Ren, et al.
ACS Nano (2021) Vol. 15, Iss. 7, pp. 11953-11969
Closed Access | Times Cited: 168
Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang, Dongzhu Duan, Zi‐Long Song, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 342-394
Closed Access | Times Cited: 144
Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management
Ping Jin, Jingwen Jiang, Li Zhou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 122
Antioxidant Therapy in Cancer: Rationale and Progress
Maochao Luo, Li Zhou, Zhao Huang, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1128-1128
Open Access | Times Cited: 112
Cancer metabolism and tumor microenvironment: fostering each other?
Yiyuan Yuan, Huimin Li, Pu Wang, et al.
Science China Life Sciences (2021) Vol. 65, Iss. 2, pp. 236-279
Closed Access | Times Cited: 106
PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma
Kui Wang, Li Luo, Shuyue Fu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 60
Phenolic compounds as Nrf2 inhibitors: potential applications in cancer therapy
Javad Sharifi‐Rad, Véronique Seidel, Michalak Izabela, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 54
Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney
Yanjuan Hou, E.H. Tan, Honghong Shi, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 30
Anchang Yuyang Decoction inhibits experimental colitis-related carcinogenesis by regulating PPAR signaling pathway and affecting metabolic homeostasis of host and microbiota
Xiunan Wei, Junwei Liang, J.-W. Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 326, pp. 117995-117995
Open Access | Times Cited: 16
Potential Applications of NRF2 Modulators in Cancer Therapy
Emiliano Panieri, Aleksandra Buha Djordjević, Pelin Telkoparan‐Akillilar, et al.
Antioxidants (2020) Vol. 9, Iss. 3, pp. 193-193
Open Access | Times Cited: 130
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors
Jinghan Zhu, Yixiao Xiong, Yuxin Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 95
Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition
George Sharbeen, Joshua A. McCarroll, Anouschka Akerman, et al.
Cancer Research (2021) Vol. 81, Iss. 13, pp. 3461-3479
Open Access | Times Cited: 91
In situ fabrication of MS@MnO2 hybrid as nanozymes for enhancing ROS-mediated breast cancer therapy
Xufeng Zhu, Yanan Liu, Guanglong Yuan, et al.
Nanoscale (2020) Vol. 12, Iss. 43, pp. 22317-22329
Open Access | Times Cited: 75
Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness
Pravat Kumar Parida, Mauricio Marquez-Palencia, Vidhya R. Nair, et al.
Cell Metabolism (2022) Vol. 34, Iss. 1, pp. 90-105.e7
Open Access | Times Cited: 64
Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms
Yuzhe Sun, Edward Davis
Nanomaterials (2021) Vol. 11, Iss. 3, pp. 746-746
Open Access | Times Cited: 61
Synthetic biology-instructed transdermal microneedle patch for traceable photodynamic therapy
Gang He, Yashi Li, Muhammad Rizwan Younis, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 60
The non-canonical effects of heme oxygenase-1, a classical fighter against oxidative stress
Jiajia Wu, Siyu Li, Cheng Li, et al.
Redox Biology (2021) Vol. 47, pp. 102170-102170
Open Access | Times Cited: 56
Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals
Lixia Dong, Jingqiu He, Li Luo, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 92-92
Open Access | Times Cited: 38
Cytoprotective Role of Heme Oxygenase-1 in Cancer Chemoresistance: Focus on Antioxidant, Antiapoptotic, and Pro-Autophagy Properties
Huan Wang, Qi Cheng, Lingjie Bao, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1217-1217
Open Access | Times Cited: 32
PdCux Bimetallic Nanoalloys with “Hand‐in‐Hand” Collaboration in POD‐like Activity and “Back‐to‐Back” Confrontation in SPR Effect for Tumor Redox System Control
Linyang Fang, Yangyang Zhang, He Ding, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 2
Closed Access | Times Cited: 30
Complex II ambiguities—FADH2 in the electron transfer system
Erich Gnaiger
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105470-105470
Open Access | Times Cited: 23
Superparamagnetic Iron Oxide Nanoparticles Reprogram the Tumor Microenvironment and Reduce Lung Cancer Regrowth after Crizotinib Treatment
Natalie K. Horvat, Sara Chocarro, Oriana Marques, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 11025-11041
Open Access | Times Cited: 14
Bimetallic PtPd Atomic Clusters as Apoptosis/Ferroptosis Inducers for Antineoplastic Therapy through Heterogeneous Catalytic Processes
Xiaoqin Wang, Mengting He, Yinmin Zhao, et al.
ACS Nano (2024) Vol. 18, Iss. 11, pp. 8083-8098
Closed Access | Times Cited: 12
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Xiaodan Jia, Yue Wang, Yue Qiao, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top